Patents by Inventor Anna M. Becher

Anna M. Becher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Flea ultraspiracle nucleic acid molecules
    Patent number: 7667019
    Abstract: The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
    Type: Grant
    Filed: April 6, 2007
    Date of Patent: February 23, 2010
    Assignee: Heska Corporation
    Inventors: Nancy Wisnewski, Anna M. Becher, Eric Jarvis
  • Flea ultraspiracle nucleic acid molecules and uses thereof
    Patent number: 7208589
    Abstract: We claim a flea ultraspiracle nucleic acid molecule encoding an ultraspiracle protein, and a composition comprising the isolated nucleic acid molecule. Also, we claim a method of recombinantly producing the ultraspiracle protein thereof.
    Type: Grant
    Filed: May 27, 2004
    Date of Patent: April 24, 2007
    Assignee: Heska Corporation
    Inventors: Nancy Wisnewski, Anna M. Becher, Eric Jarvis
  • Ultraspiracle nucleic acid molecules and uses thereof
    Publication number: 20040229273
    Abstract: The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
    Type: Application
    Filed: May 27, 2004
    Publication date: November 18, 2004
    Inventors: Nancy Wisnewski, Anna M. Becher, Eric Jarvis
  • Flea ecdysone nucleic acid molecules and uses thereof
    Patent number: 6767721
    Abstract: The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: July 27, 2004
    Inventors: Nancy Wisnewski, Anna M. Becher, Eric Jarvis
  • Novel flea ecdysone and ultraspiracle nucleic acid molecules, proteins and uses thereof
    Publication number: 20030064478
    Abstract: The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
    Type: Application
    Filed: September 25, 2002
    Publication date: April 3, 2003
    Applicant: Heska Corporation
    Inventors: Nancy Wisnewski, Anna M. Becher, Eric Jarvis
  • Flea ecdysone and ultraspiracle nucleic acid molecules, proteins and uses thereof
    Patent number: 6489140
    Abstract: The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
    Type: Grant
    Filed: November 5, 1999
    Date of Patent: December 3, 2002
    Inventors: Nancy Wisnewski, Anna M. Becher, Eric Jarvis
  • Flea chitinase nucleic acid molecules and uses thereof
    Patent number: 6416977
    Abstract: The present invention relates to flea chitinase nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes therapeutic compositions comprising such nucleic acid molecules, proteins, antibodies, and/or other inhibitors, as well as their use to protect an animal from flea infestation.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: July 9, 2002
    Assignee: Heska Corporation
    Inventor: Anna M. Becher